Technical Data
M2419-90
Matrix Gla Protein (MGP)
Description:
Applications:
Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
ELISA: 1:1000
Western Blot: 1:500
Immunohistochemistry (Frozen or paraffin): 1:200
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG16D552Affinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanMouse
Concentration:
~1mg/ml (after reconstitution)
Immunogen:
Synthetic peptide corresponding to aa3-15 of non-phosphorylated human MGP (matrix Gla protein). Species Sequence Homology: rat: 60%, mouse: 29%, porcine: 15% and equine: 19%.
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a lyophilized powder from PBS, 0.05% sodium azide. Reconstitute with 100ul sterile ddH2O.
Specificity:
Recognizes human carboxylated (functional) and non-carboxylated (non-functional) MGP.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Assay for Human Matrix Gla Protein in Serum: Potential Applications in the Cardiovascular Field: L.A. Braam, et al.; Arterioscler. Thromb. Vasc. Biol. 20, 1257 (2000) 2. Role of Vitamin K and vitamin K-dependent proteins in vascular calcification: L.J. Schurgers, et al.; Z. Kardiol. 90, 57 (2001) 3. Matrix gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall: H.M. Spronk, et al.; BBRC 289, 485 (2001)